- Home
- BFRG vs ABVC Comparison
BFRG vs ABVC Comparison
Compare BFRG & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRG
- ABVC
- Stock Information
- Founded
- BFRG 2017
- ABVC 2015
- Country
- BFRG United States
- ABVC United States
- Employees
- BFRG N/A
- ABVC N/A
- Industry
- BFRG Retail: Computer Software & Peripheral Equipment
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- BFRG Technology
- ABVC Health Care
- Exchange
- BFRG Nasdaq
- ABVC Nasdaq
- Market Cap
- BFRG 14.8M
- ABVC 16.7M
- IPO Year
- BFRG 2023
- ABVC N/A
- Fundamental
- Price
- BFRG $1.42
- ABVC $0.93
- Analyst Decision
- BFRG
- ABVC
- Analyst Count
- BFRG 0
- ABVC 0
- Target Price
- BFRG N/A
- ABVC N/A
- AVG Volume (30 Days)
- BFRG 159.6K
- ABVC 282.7K
- Earning Date
- BFRG 05-09-2025
- ABVC 05-16-2025
- Dividend Yield
- BFRG N/A
- ABVC N/A
- EPS Growth
- BFRG N/A
- ABVC N/A
- EPS
- BFRG N/A
- ABVC N/A
- Revenue
- BFRG N/A
- ABVC $509,788.00
- Revenue This Year
- BFRG N/A
- ABVC N/A
- Revenue Next Year
- BFRG N/A
- ABVC N/A
- P/E Ratio
- BFRG N/A
- ABVC N/A
- Revenue Growth
- BFRG N/A
- ABVC N/A
- 52 Week Low
- BFRG $1.43
- ABVC $0.40
- 52 Week High
- BFRG $4.84
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- BFRG 34.05
- ABVC 68.26
- Support Level
- BFRG $1.54
- ABVC $0.65
- Resistance Level
- BFRG $1.69
- ABVC $1.40
- Average True Range (ATR)
- BFRG 0.16
- ABVC 0.10
- MACD
- BFRG -0.00
- ABVC 0.05
- Stochastic Oscillator
- BFRG 7.69
- ABVC 62.03
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.